These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 18549507)

  • 1. Molecular profiling of angiogenesis in hypericin mediated photodynamic therapy.
    Bhuvaneswari R; Gan YY; Lucky SS; Chin WW; Ali SM; Soo KC; Olivo M
    Mol Cancer; 2008 Jun; 7():56. PubMed ID: 18549507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of hypericin-mediated photodynamic therapy on the expression of vascular endothelial growth factor in human nasopharyngeal carcinoma.
    Bhuvaneswari R; Gan YY; Yee KK; Soo KC; Olivo M
    Int J Mol Med; 2007 Oct; 20(4):421-8. PubMed ID: 17786271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypericin-mediated photodynamic therapy in combination with Avastin (bevacizumab) improves tumor response by downregulating angiogenic proteins.
    Bhuvaneswari R; Yuen GY; Chee SK; Olivo M
    Photochem Photobiol Sci; 2007 Dec; 6(12):1275-83. PubMed ID: 18046482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiangiogenesis agents avastin and erbitux enhance the efficacy of photodynamic therapy in a murine bladder tumor model.
    Bhuvaneswari R; Yuen GY; Chee SK; Olivo M
    Lasers Surg Med; 2011 Sep; 43(7):651-62. PubMed ID: 22057493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of hypericin-mediated photodynamic therapy in combination with angiogenesis inhibitor bevacizumab using in vivo fluorescence confocal endomicroscopy.
    Bhuvaneswari R; Thong PS; Gan YY; Soo KC; Olivo M
    J Biomed Opt; 2010; 15(1):011114. PubMed ID: 20210440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Hypocrellin B in a human bladder tumor model in experimental photodynamic therapy: biodistribution, light dose and drug-light interval effects.
    Chin W; Lau W; Cheng C; Olivo M
    Int J Oncol; 2004 Sep; 25(3):623-9. PubMed ID: 15289863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypericin-photodynamic therapy (PDT) using an alternative treatment regime suitable for multi-fraction PDT.
    Thong PS; Watt F; Ren MQ; Tan PH; Soo KC; Olivo M
    J Photochem Photobiol B; 2006 Jan; 82(1):1-8. PubMed ID: 16203156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel Insights into the Effect of Hyperforin and Photodynamic Therapy with Hypericin on Chosen Angiogenic Factors in Colorectal Micro-Tumors Created on Chorioallantoic Membrane.
    Majerník M; Jendželovský R; Babinčák M; Košuth J; Ševc J; Tonelli Gombalová Z; Jendželovská Z; Buríková M; Fedoročko P
    Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31248208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-angiogenic effects of Hypericin-photodynamic therapy in combination with Celebrex in the treatment of human nasopharyngeal carcinoma.
    Yee KK; Soo KC; Olivo M
    Int J Mol Med; 2005 Dec; 16(6):993-1002. PubMed ID: 16273277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular effectors and modulators of hypericin-mediated cell death in bladder cancer cells.
    Buytaert E; Matroule JY; Durinck S; Close P; Kocanova S; Vandenheede JR; de Witte PA; Piette J; Agostinis P
    Oncogene; 2008 Mar; 27(13):1916-29. PubMed ID: 17952126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antivascular tumor eradication by hypericin-mediated photodynamic therapy.
    Chen B; Roskams T; de Witte PA
    Photochem Photobiol; 2002 Nov; 76(5):509-13. PubMed ID: 12462645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypericin-photodynamic therapy leads to interleukin-6 secretion by HepG2 cells and their apoptosis via recruitment of BH3 interacting-domain death agonist and caspases.
    Barathan M; Mariappan V; Shankar EM; Abdullah BJ; Goh KL; Vadivelu J
    Cell Death Dis; 2013 Jun; 4(6):e697. PubMed ID: 23807226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bio-distribution and subcellular localization of Hypericin and its role in PDT induced apoptosis in cancer cells.
    Ali SM; Olivo M
    Int J Oncol; 2002 Sep; 21(3):531-40. PubMed ID: 12168096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Photodynamic therapy with hypericin induces vascular damage and apoptosis in the RIF-1 mouse tumor model.
    Chen B; Roskams T; Xu Y; Agostinis P; de Witte PA
    Int J Cancer; 2002 Mar; 98(2):284-90. PubMed ID: 11857421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-angiogenic treatment (Bevacizumab) improves the responsiveness of photodynamic therapy in colorectal cancer.
    Peng CL; Lin HC; Chiang WL; Shih YH; Chiang PF; Luo TY; Cheng CC; Shieh MJ
    Photodiagnosis Photodyn Ther; 2018 Sep; 23():111-118. PubMed ID: 29894822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heme oxygenase-1 promotes angiogenesis in urothelial carcinoma of the urinary bladder.
    Miyake M; Fujimoto K; Anai S; Ohnishi S; Kuwada M; Nakai Y; Inoue T; Matsumura Y; Tomioka A; Ikeda T; Tanaka N; Hirao Y
    Oncol Rep; 2011 Mar; 25(3):653-60. PubMed ID: 21206978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypericin-photodynamic therapy inhibits the growth of adult T-cell leukemia cells through induction of apoptosis and suppression of viral transcription.
    Xu L; Zhang X; Cheng W; Wang Y; Yi K; Wang Z; Zhang Y; Shao L; Zhao T
    Retrovirology; 2019 Feb; 16(1):5. PubMed ID: 30782173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypericin-mediated photodynamic therapy inhibits growth of colorectal cancer cells via inducing S phase cell cycle arrest and apoptosis.
    Hu J; Song J; Tang Z; Wei S; Chen L; Zhou R
    Eur J Pharmacol; 2021 Jun; 900():174071. PubMed ID: 33811836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo photodynamic activity of hypericin in transitional cell carcinoma bladder tumors.
    Zupkó I; Kamuhabwa AR; D'Hallewin MA; Baert L; De Witte PA
    Int J Oncol; 2001 May; 18(5):1099-105. PubMed ID: 11295062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypericin-mediated photodynamic therapy induces lipid peroxidation and necrosis in nasopharyngeal cancer.
    Du HY; Olivo M; Tan BK; Bay BH
    Int J Oncol; 2003 Nov; 23(5):1401-5. PubMed ID: 14532982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.